The initial treatment of acute primary closed-angle glaucoma (CAG) is directed towards lowering intraocular pressure (IOP) 
Discussion
The results indicate that no significant difference exists between the three methods of treatment. The constant feature in each group was intravenous Diamox; the variable was the frequency of Pilocarpine instillation. It is therefore a necessary consequence that multiple doses of Pilocarpine are unnecessary for the treatment of acute CAG.
This conclusion is predictable from theoretical considerations alone. Established CAG is characterized by sphincter ischaemia and variable ciliary body function. It is illogical to suppose that an atonic sphincter can be goaded into activity by a parasympathomimetic drug. Again, ciliary muscle contraction will not produce an increase in aqueous outflow since the angle is closed. What is necessary is a lowering of aqueous production by an already ischaemic ciliary body using a carbonic anhydrase inhibitor.
Why therefore give Pilocarpine at all? There would appear to be no logical reason for its use in the early treatment of an acute attack. However, once the IOP has been reduced to a lower level by Diamox, it seems reasonable to suppose that the return of sphincter muscle activity--at least in part-and the ensuing miosis, will open a closed angle. This means, in eflect, that Pilocarpine instillation should be delayed for about 3 to 4 hrs.
Are there any advantages in abandoning an intensive Pilocarpine regime? It is probable that:
(I) The incidence of variable degrees of Pilocarpine toxicity (Greco and Kelman, 1973; Epstein and Kaufman, I965) is reduced to zero. (2) In the presence of a mid-dilated pupil and normally functioning ciliary body, Pilocarpine can precipitate an acute angle closure (Mapstone, I 974) . While there is no evidence ofits occurrence in any patient described here, it could-theoretically-pievent the medical termination of an acute attack.
(3) A few litres of Pilocarpine will be saved annually.
It is therefore concluded that one of drop of Pilocarpine 3 to 4 hours after intravenous Diamox is all that is necessary in the initial treatment of acute primary CAG.
Summary
The use of intravenous Diamox with variable doses of Pilocarpine was investigated in the treatment of primary closed-angle glaucoma. It was concluded that one drop of Pilocarpine 3 to 4 hrs after intravenous Diamox is the only parasympathomimetic drug necessary to terminate an acute attack.
